- Home
- CERO vs AMIX Comparison
CERO vs AMIX Comparison
Compare CERO & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- AMIX
- Stock Information
- Founded
- CERO 2017
- AMIX 2014
- Country
- CERO United States
- AMIX United States
- Employees
- CERO N/A
- AMIX N/A
- Industry
- CERO
- AMIX
- Sector
- CERO
- AMIX
- Exchange
- CERO Nasdaq
- AMIX NYSE
- Market Cap
- CERO 8.4M
- AMIX 7.3M
- IPO Year
- CERO N/A
- AMIX N/A
- Fundamental
- Price
- CERO $2.34
- AMIX $3.14
- Analyst Decision
- CERO
- AMIX
- Analyst Count
- CERO 0
- AMIX 0
- Target Price
- CERO N/A
- AMIX N/A
- AVG Volume (30 Days)
- CERO 80.5M
- AMIX 967.7K
- Earning Date
- CERO 02-20-2025
- AMIX 02-11-2025
- Dividend Yield
- CERO N/A
- AMIX N/A
- EPS Growth
- CERO N/A
- AMIX N/A
- EPS
- CERO N/A
- AMIX N/A
- Revenue
- CERO N/A
- AMIX N/A
- Revenue This Year
- CERO N/A
- AMIX N/A
- Revenue Next Year
- CERO N/A
- AMIX N/A
- P/E Ratio
- CERO N/A
- AMIX N/A
- Revenue Growth
- CERO N/A
- AMIX N/A
- 52 Week Low
- CERO $2.22
- AMIX $2.55
- 52 Week High
- CERO $1,280.00
- AMIX $152.00
- Technical
- Relative Strength Index (RSI)
- CERO 32.54
- AMIX 41.37
- Support Level
- CERO $2.83
- AMIX $2.55
- Resistance Level
- CERO $3.50
- AMIX $3.30
- Average True Range (ATR)
- CERO 1.13
- AMIX 0.44
- MACD
- CERO 0.05
- AMIX 0.18
- Stochastic Oscillator
- CERO 1.43
- AMIX 29.06
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.